Kidneys and Genito-Urinary System Benign Prostatic Hyperplasia

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Benign Prostatic Hyperplasia Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Benign Prostatic Hyperplasia Projects
--Allergan Inc
--AEterna Zentaris Inc
--Bayer Ag
--Ardana plc
--Choongwae Pharma Corporation
--BioXell S.p.A.
--Eli Lilly & Co
--DAIICHI SANKYO COMPANY, LIMITED
--Kissei Pharmaceutical Co., Ltd.
--GlaxoSmithKline plc
--Nippon Kayaku Co., Ltd.
--Milkhaus Laboratory, Inc.
--Ranbaxy Laboratories Ltd.
--Nymox Pharmaceutical Corporation
--Shionogi & Co., Ltd.
--RECORDATI SpA
--Teva Pharmaceutical Industries Ltd
--Spectrum Pharmaceuticals Inc

--Top Companies in early stage Benign Prostatic Hyperplasia Projects
--AndroScience Corporation
--Aphios Corporation
--Daewoong Pharmaceutical Co. Ltd.
--GTX INC/TN
--Neurocrine Biosciences Inc
--Pherin Pharmaceuticals, Inc.
--Protox Therapeutics Inc.
--Ranbaxy Laboratories Ltd.
--RECORDATI SpA
--Rottapharm SpA

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View